You are here
The Independent Hospital Pricing Authority (IHPA) is currently developing a new classification for non-admitted care - the Australian Non-Admitted Care Classification (ANACC) - in response to the recommendations of public consultations in 2013 and 2014 on non-admitted care classification.
The Tier 2 Non-Admitted Services Compendium provides guidance on the counting and classification rules associated with the Tier 2 Non-Admitted Services Classification (Tier 2).
The Tier 2 Non-Admitted Services Classification (Tier 2) supports the introduction of activity based funding (ABF) for non-admitted hospital services in the Australian public hospital system.
Report for the counting, costing and classifying of Non-Admitted Multidisciplinary Case Conferences (MDCCs) where patient is not present17 May 2017
IHPA commissioned a study of the counting, costing and classifying of multidisciplinary case conferences (MDCCs) for non-admitted patients, when the patient is not present. MDCCs have become a more common and important aspect of clinical care. The increasing complexity and specialisation in health care has driven the need for more formalised mechanisms for multidisciplinary collaboration.
The purpose of this costing study was to undertake a Teaching, Training and Research (TTR) cost and activity data collection at a representative sample of Australian hospitals and produce costed data to inform the development of a TTR classification.
The non-admitted study was comprehensive across a range of settings (e.g. outpatients, community and satellite clinics). Similarly all service streams were included regardless of funding source. This ensured that all services were accounted for and costed appropriately providing an accurate cost of delivering multiple services across multiple settings (e.g. overhead costs are apportioned across all patients).
The costing study on home delivered dialysis was undertaken in 2014. The purpose of the study was to collate and compare the range of costing studies and economic evaluations that have been carried out on these services over the past decade.
The report identifies two key studies - NSW Dialysis Costing Study, conducted in 2008, and Queensland Health Renal Replacement Therapy Costing Study, conducted in 2008 - which are useful in estimating the current costs of home-based dialysis.
PwC and its sub-contractor The Independent Hospital Pricing Authority (IHPA) engaged PwC and its sub-contractor SyRis Consulting to undertake a review and costing study of Australian radiotherapy services. The study was commissioned to determine the reliability of radiotherapy cost data due to its role in the development of associated price weights in both admitted and non-admitted settings.
Submissions were forwarded to IHPA in a range of formats including Word, RTF, PDF and handwritten or typed hardcopy. In order to make submissions available as soon as possible, most submissions have been published in their original format. Handwritten submissions have been scanned into PDF documents. If the content has been emailed to IHPA the text of email submissions has been reproduced in Word format.